Pharmacokinetics of anti‐TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|S3|S39-S50

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.S3, 2015-03, pp. : S39-S50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 33, Iss. 1, 2015-09 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease

By  

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 594-598

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease

By  

Current Drug Metabolism, Vol. 15, Iss. 9, 2014-11 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1421-1432

Bentham Science Publishers

Access to resources Recommend Favorite

Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents

By Guerra Iván   Gisbert Javier P  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 1, 2013-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite